China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
扑尔敏原料药垄断
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (国家市场监督管理总局 · 处罚决定书国市监处〔2018〕21号; 处罚决定书国市监处〔2018〕22号 · 市场监管总局发布扑尔敏原料药垄断案行政处罚决定书), from 18 January 2019.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 扑尔敏原料药垄断
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 国家市场监督管理总局 · 处罚决定书国市监处〔2018〕21号; 处罚决定书国市监处〔2018〕22号 · 市场监管总局发布扑尔敏原料药垄断案行政处罚决定书
- From
- 18 January 2019
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_6932b20481d941b48a4733092e044752.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)